Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells
- 1 March 2003
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 53 (6) , 530-537
- https://doi.org/10.1016/s0006-3223(02)01551-2
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medicationBiological Psychiatry, 2001
- Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2000
- Sequencing the Entire Genomes of Free-Living Organisms: The Foundation of Pharmacology in the New MillenniumAnnual Review of Pharmacology and Toxicology, 2000
- Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signallingJournal of Neuroscience Research, 2000
- Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA LevelJournal of Neuroscience, 1999
- GAP-43: an intrinsic determinant of neuronal development and plasticityTrends in Neurosciences, 1997
- Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic miceCell, 1995
- Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combinationJournal of Neuroscience Research, 1993
- Effects of repeated administration of desipramine or electroconvulsive shock on norepinephrine uptakes sites measured by [3H]nisoxetine autoradiographyBrain Research, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976